Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hua Han Bio-Pharmaceutical Holdings Ltd

+ Add to Watchlist

587:HK

2.340 HKD 0.070 2.90%

As of 04:01:04 ET on 04/17/2015.

Snapshot for Hua Han Bio-Pharmaceutical Holdings Ltd (587)

Open: 2.370 Day's Range: 2.330 - 2.420 Volume: 23,269,027
Previous Close: 2.410 52wk Range: 1.167 - 2.870 1-Yr Rtn: +67.93%

Stock Chart for 587

No chart data available.
  • 587:HK 2.340
  • 1D
  • 1M
  • 1Y
2.410
Interactive 587 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 587

Current P/E Ratio (ttm) 34.4540
Estimated P/E(06/2015) 21.2727
Relative P/E vs. HSI 2.9524
Earnings Per Share (HKD) (ttm) 0.0679
Est. EPS (HKD) (06/2015) 0.1100
Est. PEG Ratio -
Market Cap (M HKD) 11,500.38
Shares Outstanding (M) 4,914.69
30 Day Average Volume 30,289,220
Price/Book (mrq) 2.1529
Price/Sale (ttm) 7.0050
Dividend Indicated Gross Yield 1.28%
Cash Dividend (HKD) 0.0300
Dividend Ex-Date 01/02/2015
5 Year Dividend Growth 21.67%
Next Earnings Announcement 09/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 587

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 587

Hua Han Bio-Pharmaceutical Holdings Limited, through its subsidiaries, researches, develops, manufactures, and sells Chinese herbal pharmaceutical products primarily for women and the elderly under its Yeosure brand name. The Company also researches, develops, manufactures, and sells naturally-sourced anti-tumor medicines and western pharmaceutical products.

Zhang Peter YChairman/Co-FounderDeng JieCEO/Co-Founder
Zhang Bing ShengChief Investment SupervisorNiu YiChief Inspector:Human Resource
More Company Profile & Key Executives for 587

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil